"10.1371_journal.pone.0082535","plos one","2013-12-17T00:00:00Z","Christine van der Leeuw; Machteld Marcelis; Sanne C T Peeters; Marcel M Verbeek; Paul P C A Menheere; Lieuwe de Haan; Jim van Os; Nico J M van Beveren; for Genetic Risk and Outcome in Psychosis (G.R.O.U.P.)","Department of Psychiatry and Psychology, School for Mental Health and Neuroscience, European Graduate School of Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands; Departments of Neurology and Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands; Central Diagnostic Laboratory, Maastricht University Medical Centre, Maastricht, The Netherlands; Deparment of Psychiatry, Academic Medical Centre, Amsterdam, The Netherlands; Kings College London, Kings Health Partners, Department of Psychosis Studies, Institute of Psychiatry, London, United Kingdom; Departments of Psychiatry and Neuroscience, Erasmus Medical Centre, Rotterdam, The Netherlands; Department Nieuwe Kennis, Delta Centre for Mental Health Care, Rotterdam, The Netherlands","Conceived and designed the experiments: MM LdH JvO NvB. Performed the experiments: SP. Analyzed the data: CvdL MM. Contributed reagents/materials/analysis tools: MV PM. Wrote the paper: CvdL MM JvO NvB.","Jim van Os is or has been an unrestricted research grant holder with, or has received financial compensation as an independent symposium speaker from, Eli Lilly, BMS, Lundbeck, Organon, Janssen-Cilag, GlaxoSmithKline, AstraZeneca, Pfizer and Servier. Machteld Marcelis has received financial compensation as an independent symposium speaker from Eli Lilly and Janssen-Cilag. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials. All other authors report no biomedical financial interests or potential conflicts of interest.","2013","12","Christine van der Leeuw","CVDL",9,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
